CMEOF (Creo Medical Group) Interest Expense: $-0.40 Mil (TTM As of Dec. 2025)

What is Creo Medical Group Interest Expense?

Creo Medical Group CMEOF 52 Interest Expense is $-0.40 Mil as of Dec. 2025. GuruFocus rates CMEOF with a GF Score™ of 52/100 and a GF Value™ of $0.25. The stock has 6 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Creo Medical Group's interest expense for the six months ended in Dec. 2025 was $ -0.27 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.40 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Creo Medical Group's Operating Income for the six months ended in Dec. 2025 was $ -12.72 Mil. Creo Medical Group's Interest Expense for the six months ended in Dec. 2025 was $ -0.27 Mil. Creo Medical Group did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Creo Medical Group (OTCPK:CMEOF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Creo Medical Group's Interest Expense for the six months ended in Dec. 2025 was $-0.27 Mil. Its Operating Income for the six months ended in Dec. 2025 was $-12.72 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was $2.41 Mil.

Creo Medical Group's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Creo Medical Group did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Creo Medical Group Interest Expense Historical Data

* Premium members only.

The historical data trend for Creo Medical Group's Interest Expense can be seen below:

Creo Medical Group Interest Expense Chart

Creo Medical Group Annual Data

Trend

Feb15

Feb16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.48

-0.37

-0.25

-0.51

-0.40

Creo Medical Group Semi-Annual Data
	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Interest Expense	Get a 7-Day Free Trial															-0.13	-0.13	-0.38	-0.14	-0.27

52GF Score

Creo Medical Group PLC CMEOF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Creo Medical Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.40 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.40 Mil mean?

Creo Medical Group (CMEOF) has a Interest Expense of $-0.40 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Creo Medical Group and its competitors.

Is Creo Medical Group's Interest Expense too high?

Creo Medical Group's current Interest Expense is $-0.40 Mil. Overall, Creo Medical Group has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.

How does Creo Medical Group's Interest Expense compare to ABT and SYK?

Creo Medical Group's Interest Expense of $-0.40 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Creo Medical Group and its competitors. Creo Medical Group's current Interest Expense is $-0.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Creo Medical Group stock overvalued right now?

Creo Medical Group (CMEOF) has a current Interest Expense of $-0.40 Mil. The stock's GF Value™ is $0.25, compared to a current price of $0.20 — trading 20% below its estimated fair value. The current Interest Expense is $-0.40 Mil. Creo Medical Group's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Creo Medical Group (CMEOF), the current Interest Expense is $-0.40 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Creo Medical Group (CMEOF) Overvalued in 2026?

Based on GuruFocus' analysis, Creo Medical Group stock appears to be undervalued. The current stock price of $0.20 is trading 20% below its estimated GF Value™ of $0.25.

Key valuation signals for CMEOF:

Interest Expense: $-0.40 Mil
GF Value™: $0.25 vs. price of $0.20 (20% below fair value)
GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the CMEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Creo Medical Group Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies LSE:AOTI LSE:IHC LSE:EKF LSE:SUN LSE:NIOX ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760 STE ZBH XSWX:SOON LSE:SN.PEN

Other Exchanges CREO:UK

Address Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH

Website https://www.creomedical.com

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world.

52GF Score

Get the complete analysis for CMEOF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20

Price

$0.25

GF Value

View CMEOF Analysis

See Interest Expense data for all stocks →